Lake RA - Search Results

1

Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity.

Marzo AL, Kinnear BF, Lake RA, Frelinger JJ, Collins EJ, Robinson BW, Scott B. Marzo AL, et al. Among authors: lake ra. J Immunol. 2000 Dec 1;165(11):6047-55. doi: 10.4049/jimmunol.165.11.6047. J Immunol. 2000. PMID: 11086036

2

Cytokine gene therapy or infusion as treatment for solid human cancer.

Robinson BW, Mukherjee SA, Davidson A, Morey S, Musk AW, Ramshaw I, Smith D, Lake R, Haenel T, Garlepp M, Marley J, Leong C, Caminschi I, Scott B. Robinson BW, et al. J Immunother. 1998 May;21(3):211-7. doi: 10.1097/00002371-199805000-00007. J Immunother. 1998. PMID: 9610913

3

Sera from patients with malignant mesothelioma can contain autoantibodies.

Robinson C, Robinson BW, Lake RA. Robinson C, et al. Among authors: lake ra. Lung Cancer. 1998 Jun;20(3):175-84. doi: 10.1016/s0169-5002(98)00014-2. Lung Cancer. 1998. PMID: 9733052

4

T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumors.

Marzo AL, Lake RA, Robinson BW, Scott B. Marzo AL, et al. Among authors: lake ra. Cancer Res. 1999 Mar 1;59(5):1071-9. Cancer Res. 1999. PMID: 10070965

5

MHC multimerization, antigen expression and the induction of APC amnesia in the developing immune response.

Lake RA, Robinson BW, Hayball JD. Lake RA, et al. Immunol Cell Biol. 1999 Feb;77(1):99-104. doi: 10.1046/j.1440-1711.1999.00794.x. Immunol Cell Biol. 1999. PMID: 10101691 Review.

6

Tumor antigens are constitutively presented in the draining lymph nodes.

Marzo AL, Lake RA, Lo D, Sherman L, McWilliam A, Nelson D, Robinson BW, Scott B. Marzo AL, et al. Among authors: lake ra. J Immunol. 1999 May 15;162(10):5838-45. J Immunol. 1999. PMID: 10229818

7

Cross-presentation of tumour antigens: evaluation of threshold, duration, distribution and regulation.

Robinson BW, Lake RA, Nelson DJ, Scott BA, Marzo AL. Robinson BW, et al. Among authors: lake ra. Immunol Cell Biol. 1999 Dec;77(6):552-8. doi: 10.1046/j.1440-1711.1999.00876.x. Immunol Cell Biol. 1999. PMID: 10571677 Review.

8

Serologic responses in patients with malignant mesothelioma: evidence for both public and private specificities.

Robinson C, Callow M, Stevenson S, Scott B, Robinson BW, Lake RA. Robinson C, et al. Among authors: lake ra. Am J Respir Cell Mol Biol. 2000 May;22(5):550-6. doi: 10.1165/ajrcmb.22.5.3930. Am J Respir Cell Mol Biol. 2000. PMID: 10783126

9

Replication-restricted vaccinia as a cytokine gene therapy vector in cancer: persistent transgene expression despite antibody generation.

Mukherjee S, Haenel T, Himbeck R, Scott B, Ramshaw I, Lake RA, Harnett G, Phillips P, Morey S, Smith D, Davidson JA, Musk AW, Robinson B. Mukherjee S, et al. Among authors: lake ra. Cancer Gene Ther. 2000 May;7(5):663-70. doi: 10.1038/sj.cgt.7700133. Cancer Gene Ther. 2000. PMID: 10830713 Clinical Trial.

10

New chemotherapeutics in malignant mesothelioma: effects on cell growth and IL-6 production.

McLaren BR, Robinson BW, Lake RA. McLaren BR, et al. Among authors: lake ra. Cancer Chemother Pharmacol. 2000;45(6):502-8. doi: 10.1007/s002800051026. Cancer Chemother Pharmacol. 2000. PMID: 10854139

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters